Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Antibody Drug Conjugates Market, by Application
1.4.2 LAMEA Antibody Drug Conjugates Market, by Technology
1.4.3 LAMEA Antibody Drug Conjugates Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition & mergers
3.2.3 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2018, May – 2022, Mar) Leading Players
Chapter 4. LAMEA Antibody Drug Conjugates Market by Application
4.1 LAMEA Breast Cancer Market by Country
4.2 LAMEA Blood Cancer Market by Country
4.3 LAMEA Urothelial Cancer & Bladder Cancer?Market by Country
4.4 LAMEA Others Market by Country
Chapter 5. LAMEA Antibody Drug Conjugates Market by Technology
5.1 LAMEA Cleavable Linker Market by Country
5.2 LAMEA Non-Cleavable Linker Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Antibody Drug Conjugates Market by Country
6.1 Brazil Antibody Drug Conjugates Market
6.1.1 Brazil Antibody Drug Conjugates Market by Application
6.1.2 Brazil Antibody Drug Conjugates Market by Technology
6.2 Argentina Antibody Drug Conjugates Market
6.2.1 Argentina Antibody Drug Conjugates Market by Application
6.2.2 Argentina Antibody Drug Conjugates Market by Technology
6.3 UAE Antibody Drug Conjugates Market
6.3.1 UAE Antibody Drug Conjugates Market by Application
6.3.2 UAE Antibody Drug Conjugates Market by Technology
6.4 Saudi Arabia Antibody Drug Conjugates Market
6.4.1 Saudi Arabia Antibody Drug Conjugates Market by Application
6.4.2 Saudi Arabia Antibody Drug Conjugates Market by Technology
6.5 South Africa Antibody Drug Conjugates Market
6.5.1 South Africa Antibody Drug Conjugates Market by Application
6.5.2 South Africa Antibody Drug Conjugates Market by Technology
6.6 Nigeria Antibody Drug Conjugates Market
6.6.1 Nigeria Antibody Drug Conjugates Market by Application
6.6.2 Nigeria Antibody Drug Conjugates Market by Technology
6.7 Rest of LAMEA Antibody Drug Conjugates Market
6.7.1 Rest of LAMEA Antibody Drug Conjugates Market by Application
6.7.2 Rest of LAMEA Antibody Drug Conjugates Market by Technology
Chapter 7. Company Profiles
7.1 Takeda Pharmaceutical Company Limited
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.1 Recent strategies and developments:
7.1.1.1 Partnerships, Collaborations, and Agreements:
7.1.1.2 Acquisitions and Mergers:
7.2 F. Hoffmann-La Roche Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 AstraZeneca PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.4 GlaxoSmithKline PLC
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Approvals and Trials:
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional & Segmental Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations and Agreements:
7.6 Astellas Pharma, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Approvals and Trials:
7.7 Gilead Sciences, Inc.
7.7.1 Company overview
7.7.2 Financial Analysis
7.7.3 Research & Development Expenses
7.7.4 Recent strategies and developments:
7.7.4.1 Acquisitions and Mergers:
7.7.4.2 Partnerships, Collaborations and Agreements:
7.8 Seagen, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Research & Development Expenses
7.8.4 Recent strategies and developments:
7.8.4.1 Partnerships, Collaborations, and Agreements:
7.9 ADC Therapeutics SA
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Research & Development Expenses
7.9.4 Recent strategies and developments:
7.9.4.1 Partnerships, Collaborations, and Agreements:
7.9.4.2 Approvals and Trials:
7.10. Daiichi Sankyo Company, Limited
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Research & Development Expense
7.10.4 Recent strategies and developments:
7.10.4.1 Partnerships, Collaborations, and Agreements:



List of Tables

TABLE 1 LAMEA Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Antibody Drug Conjugates Market
TABLE 4 Acquisition & mergers – Antibody Drug Conjugates Market
TABLE 5 Approvals and trials– Antibody Drug Conjugates Market
TABLE 6 LAMEA Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 7 LAMEA Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 8 LAMEA Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 9 LAMEA Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 10 LAMEA Blood Cancer Market by Country, 2018 - 2021, USD Million
TABLE 11 LAMEA Blood Cancer Market by Country, 2022 - 2028, USD Million
TABLE 12 LAMEA Urothelial Cancer & Bladder Cancer?Market by Country, 2018 - 2021, USD Million
TABLE 13 LAMEA Urothelial Cancer & Bladder Cancer?Market by Country, 2022 - 2028, USD Million
TABLE 14 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 15 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 16 LAMEA Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 17 LAMEA Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 18 LAMEA Cleavable Linker Market by Country, 2018 - 2021, USD Million
TABLE 19 LAMEA Cleavable Linker Market by Country, 2022 - 2028, USD Million
TABLE 20 LAMEA Non-Cleavable Linker Market by Country, 2018 - 2021, USD Million
TABLE 21 LAMEA Non-Cleavable Linker Market by Country, 2022 - 2028, USD Million
TABLE 22 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 23 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 24 LAMEA Antibody Drug Conjugates Market by Country, 2018 - 2021, USD Million
TABLE 25 LAMEA Antibody Drug Conjugates Market by Country, 2022 - 2028, USD Million
TABLE 26 Brazil Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 27 Brazil Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 28 Brazil Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 29 Brazil Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 30 Brazil Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 31 Brazil Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 32 Argentina Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 33 Argentina Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 34 Argentina Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 35 Argentina Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 36 Argentina Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 37 Argentina Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 38 UAE Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 39 UAE Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 40 UAE Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 41 UAE Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 42 UAE Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 43 UAE Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 44 Saudi Arabia Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 45 Saudi Arabia Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 46 Saudi Arabia Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 47 Saudi Arabia Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 48 Saudi Arabia Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 49 Saudi Arabia Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 50 South Africa Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 51 South Africa Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 52 South Africa Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 53 South Africa Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 54 South Africa Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 55 South Africa Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 56 Nigeria Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 57 Nigeria Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 58 Nigeria Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 59 Nigeria Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 60 Nigeria Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 61 Nigeria Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 62 Rest of LAMEA Antibody Drug Conjugates Market, 2018 - 2021, USD Million
TABLE 63 Rest of LAMEA Antibody Drug Conjugates Market, 2022 - 2028, USD Million
TABLE 64 Rest of LAMEA Antibody Drug Conjugates Market by Application, 2018 - 2021, USD Million
TABLE 65 Rest of LAMEA Antibody Drug Conjugates Market by Application, 2022 - 2028, USD Million
TABLE 66 Rest of LAMEA Antibody Drug Conjugates Market by Technology, 2018 - 2021, USD Million
TABLE 67 Rest of LAMEA Antibody Drug Conjugates Market by Technology, 2022 - 2028, USD Million
TABLE 68 Key Information – Takeda Pharmaceutical Company Limited
TABLE 69 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 70 KEY INFORMATION – ASTRAZENECA PLC
TABLE 71 Key Information – GlaxoSmithKline PLC
TABLE 72 Key Information – Pfizer, Inc.
TABLE 73 key information – Astellas Pharma, Inc.
TABLE 74 Key Information – Gilead Sciences, Inc.
TABLE 75 Key Information – Seagen Inc.
TABLE 76 Key Information – ADC Therapeutics SA
TABLE 77 Key Information – Daiichi Sankyo Company, Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2018, May – 2022, Mar) Leading Players
FIG 5 Recent strategies and developments: Takeda Pharmaceutical Company Limited
FIG 6 Recent strategies and developments: Gilead Sciences, Inc.